Khaled Alhamad
University of Utah · 14 works · 46 citations · h-index 3
Top works
- The use of immunotherapy treatment in malignant pheochromocytomas/paragangliomas: a case report
- Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma
- Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study
- An internal review of chemotherapy toxicities in patients with pancreatic cancer.
- A Multicenter Study Analyzing Survival and Prognostic Factors in Patients with Leukemic Phase Follicular Lymphoma
- Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A real-world perspective.
- Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Extranodal (EN) B-Cell Non-Hodgkin Lymphoma (NHL): Results from a Multicenter Analysis
- Surgical outcomes and rate of pathological response in resectable/borderline resectable pancreatic cancer patients undergoing neoadjuvant gemcitabine/nab-paclitaxel versus FOLFIRINOX: A retrospective institutional analysis.
- Outcomes in primary gastrointestinal (GI) follicular lymphoma (FL): results from a multicenter analysis
- Neoadjuvant chemotherapy and disease recurrence after curative-intent surgery in patients with pancreatic adenocarcinoma: A single-center retrospective review.
- Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study
- P3.13C.09 First-Line Treatments for Advanced Pure Large Cell Neuroendocrine Tumors (LCNEC):Insights from a Global Clinico-Genomic Study
- Comparison of survival outcomes with the use of combination chemoimmunotherapy versus immunotherapy alone in NSCLC with high PD-L1 expression.
- Impact of Immune-Related Adverse Events on Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Real-World Perspective